This is an update to the study registered by the https://clinicaltrials.gov web site what was initially posted in this post.
The updated information is accessible here:
https://clinicaltrials.gov/ct2/show/NCT03058705
The updated dates indicate that study is set to commence on October 1, 2017. I'm not certain whether this update was triggered by any developments on the IRB approval front (i.e. an imminent approval) or an update in the normal course as the dates were stale.
Management has indicated the IRB should be approved this month so hopefully it is the former, not the latter.
JB
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM